Hydrogen Breath Test an Instrument to Predict Rifaximin-Response in Irritable Bowel Syndrome Predominant Diarrhea

Clinical trial NCT03729271 · COMPLETED

Trial details

NCT number: NCT03729271
Sponsor: University of Michigan
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Irritable Bowel Syndrome Irritable Bowel Syndrome With Diarrhea

Start date: 2020-01-09
Primary completion: 2026-01-01
Enrollment: 148

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.